7 Undervalued Penny Stocks to Buy for Massive Gains

In This Article:

Undervalued penny stocks have an allure for investors for the simple reason that a little bit goes a long way. Specifically, a small investment that produces a little gain can be very rewarding for investors. But the potential reward comes with outsized risk. These are companies with small market caps that can be easy for investors to manipulate.

But how do you find penny stocks that fit this criteria? With many penny stocks, defining valuation can be tricky. Many of these companies are not yet profitable. And some are generating little revenue.

In this article, I’m looking at seven penny stocks that have the potential to pay off for investors down the road. Let me be clear. I’m not suggesting that any of these stocks will deliver quick, short-term profits. However, if you have a long-term outlook and are comfortable with throwing a few of your investing darts at some undervalued penny stocks, these may be intriguing choices.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Ticker

Company

Current Price

SENS

Senseonics

$1.16

CIDM

Cindigm

67 cents

RMO

Romeo Power

72 cents

IDEX

Ideanomics

74 cents

GHSI

Guardion Health Sciences

17 cents

SHIP

Seanergy Maritime Holdings

$1.10

MUX

McEwen Mining

58 cents

Senseonics (SENS)

Diabetes remains one of the most prevalent chronic health conditions that individuals need to manage. And Senseonics (NYSE:SENS) has a product, Eversense, that is an implanted glucose monitor for diabetics. As Dana Blakenhorn wrote in December 2021, Senseonics has “a real product with serious potential.”

That makes the company intriguing to me. It’s focusing on one thing and trying to do that one thing really well. On the other hand, the market for implanted glucose monitoring is already getting crowded. Senseonics is competing against names like Dexcom (NASDAQ:DXCM) and Abbott Laboratories (NYSE:ABT) today. And down the road, Apple (NASDAQ:AAPL) may be entering the fray.

Senseonics is not yet profitable. And while it is projecting strong revenue growth over the next five years, it is still unlikely to be profitable. However, with a stock that’s currently trading slightly above $1, a little bit of growth can go a long way.

Cinedigm (CIDM)

In a world where consumers are already showing signs of looking past streaming to the next new thing, Cinedigm (NASDAQ:CIDM) may be offering just that. That’s a big promise, but here’s what I mean. One of the benefits of streaming early on was that consumers could find the content they wanted to watch as opposed to paying for 300 channels and only using 30. However, as streaming companies have reached scale, they’ve essentially become like traditional cable. There’s a lot of content, but maybe not that much that you really want to watch.